SEC Form 4 · accession 0001225208-16-042550
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Link Ph.D.
Director
Period of report
Nov 29, 2016
Accepted (ET)
Dec 1, 2016 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Nov 29, 2016 | S | 15,000 | $84.009 | D | 28,000 | I | * |
| Common StockF2 | holding | — | — | — | 21,974 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $83.88 to $84.21. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F2Since the date of the Reporting Person's last report, 10,000 shares previously owned by the Link Family Trust were transferred to the William Link IRA and therefore are now reported as owned directly. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
- F3Held by the Link Family Trust, DTD 5/31/1990 and the Link Family Enterprise, LLC.